Source:http://linkedlifedata.com/resource/pubmed/id/19265143
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-3-6
|
pubmed:abstractText |
In vivo data suggest that monocytes participate critically in cross-presentation, but other data suggest that lymph node resident dendritic cells (DCs) mainly cross-present. Here, we utilized a three-dimensional model of a blood vessel wall that endogenously supports DC development from human monocytes, and we incorporated dying autologous cells in the subendothelial matrix of the model. Flu-infected dying cells promoted monocytes to become mature DCs and cross-present cell-associated Ags for the activation of CTLs. Similar responses were induced by loading the dying cells with the TLR7/8 ligand ssRNA, whereas dying cells loaded with TLR3 ligand were less efficient. Monocyte-derived DCs that developed in this model cross-presented Ag to T cells efficiently regardless of whether they engulfed detectable amounts of labeled dying cells. Unexpectedly, the monocyte-derived cells that directly engulfed dying cells in vitro were not the major APCs stimulating CD8(+) lymphocytes. Instead, bystander DCs acquired more robust capacity to cross-prime through receipt of MHC class I/peptide from the phagocytic, monocyte-derived cells. In mice, lymph node-homing monocyte-derived DCs processed Ags from engulfed cells and then transferred MHC class I/peptide complexes to confer cross-priming capacity to MHC class I-deficient lymph node resident CD8alpha(+) DCs. Thus, natural or synthetic TLR7/8 agonists contained within dying cells promote the conversion of monocytes to DCs with capacity for cross-presentation and for "cross-dressing" other DCs. These data reveal a way in which migratory monocyte-derived DCs and other DCs, like lymph node resident DCs, both mediate cross-presentation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
182
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3650-9
|
pubmed:meshHeading |
pubmed-meshheading:19265143-Animals,
pubmed-meshheading:19265143-Antigen-Presenting Cells,
pubmed-meshheading:19265143-Apoptosis,
pubmed-meshheading:19265143-Cell Line,
pubmed-meshheading:19265143-Cell Line, Transformed,
pubmed-meshheading:19265143-Cell Movement,
pubmed-meshheading:19265143-Cells, Cultured,
pubmed-meshheading:19265143-Coculture Techniques,
pubmed-meshheading:19265143-Cross-Priming,
pubmed-meshheading:19265143-Dendritic Cells,
pubmed-meshheading:19265143-Female,
pubmed-meshheading:19265143-HLA-A2 Antigen,
pubmed-meshheading:19265143-Humans,
pubmed-meshheading:19265143-Mice,
pubmed-meshheading:19265143-Mice, Inbred C57BL,
pubmed-meshheading:19265143-Monocytes,
pubmed-meshheading:19265143-Peptides,
pubmed-meshheading:19265143-Phagocytosis,
pubmed-meshheading:19265143-Protein Transport
|
pubmed:year |
2009
|
pubmed:articleTitle |
MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells.
|
pubmed:affiliation |
Department of Gene and Cell Medicine and Institute for Immunology, Icahn Medical Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|